"ROUSTRIN F 20: Comprehensive Heart Health with Rosuvastatin, Fenofibrate"

ROUSTRIN F 20 

Rosuvastatin (20mg), Fenofibron (160mg)

Introduction to Rosuvastatin (20mg) and Fenofibrate (160mg)

ROUSTRIN F 20, combining Rosuvastatin (20mg) and Fenofibrate (160mg), is an advanced medication formulated to effectively manage lipid disorders. This combination therapy targets high cholesterol and triglyceride levels, offering comprehensive cardiovascular protection.

How ROUSTRIN F 20 Works

Rosuvastatin is a statin that inhibits the enzyme HMG-CoA reductase in the liver, responsible for producing cholesterol. By lowering cholesterol levels, Rosuvastatin helps prevent the buildup of plaques in the arteries, reducing the risk of heart attacks and strokes.

Fenofibrate is a fibric acid derivative that reduces triglycerides and increases high-density lipoprotein (HDL) cholesterol. It activates peroxisome proliferator-activated receptors (PPARs), crucial for lipid metabolism, thereby improving the lipid profile.

Uses of Rosuvastatin (20mg) and Fenofibrate (160mg)

ROUSTRIN F 20 is primarily used for:

• Lowering high cholesterol and triglyceride levels
• Reducing the risk of cardiovascular events, such as heart attacks and strokes
• Managing mixed dyslipidemia

Dosage and Administration

The typical dosage of ROUSTRIN F 20 is one tablet taken once daily. It is essential to follow the healthcare provider's instructions precisely. Taking the medication at the same time each day enhances its effectiveness.

Potential Side Effects

While ROUSTRIN F 20 is generally well-tolerated, some patients may experience side effects, including:

• Muscle pain or weakness
• Headache
• Dizziness
• Abdominal pain
• Increased liver enzymes

Precautions and Warnings

Before starting ROUSTRIN F 20, patients should inform their healthcare provider about any existing medical conditions, particularly:

• Liver or kidney problems
• History of muscle disorders
• Allergies to any component of the medication

Pregnant or breastfeeding women should avoid using ROUSTRIN F 20 due to potential risks to the fetus or infant.

Conclusion

ROUSTRIN F 20, combining Rosuvastatin (20mg) and Fenofibrate (160mg), offers significant benefits for managing lipid disorders. By lowering cholesterol levels and triglycerides, this medication helps reduce the risk of cardiovascular events and improve overall heart health. Always consult with a healthcare provider for personalized advice and treatment plans.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW